Results showed that the plasma sEV protein LAMB1 had significantly higher expression levels in the metastatic group of PCa patients compared to the high‐risk and control groups [healthy and benign prostatic hyperplasia (BPH) participants]. Here, LAMB1 is linked to benign prostatic hyperplasia.